{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:35:54Z","timestamp":1791408954880,"version":"4.3.3"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T00:00:00Z","timestamp":1443398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138343","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T13:45:21Z","timestamp":1443447921000},"page":"e0138343","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct02455908","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alice","family":"Bonanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bertelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"issue":"8425","key":"ref1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","article-title":"Long-term outcome for children with minimal-change nephrotic syndrome","volume":"1","author":"RS Trompeter","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"F Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"ref3","article-title":"Regulatory T cells and Minimal Change Nephropathy: in the mid of a complex network","author":"R Bertelli","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"J Reiser","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"EH Garin","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"ref6","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"CC Yu","year":"2013","journal-title":"N Engl J Med"},{"issue":"13","key":"ref7","first-page":"1263","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"370","author":"N Alachkar","year":"2014","journal-title":"N Engl J Med"},{"issue":"2\u20133","key":"ref8","first-page":"77","article-title":"Multiple mechanisms for doxorubicin cytotoxicity on glomerular epithelial cells 'in vitro'","volume":"228","author":"GM Ghiggeri","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.1991.176","article-title":"Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro","volume":"40","author":"GM Ghiggeri","year":"1991","journal-title":"Kidney Int"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0780283","article-title":"Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis","volume":"78","author":"F Ginevri","year":"1990","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome","volume":"20","author":"L Le Berre","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1681\/ASN.2011090914","article-title":"CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis","volume":"23","author":"YM Wang","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.172.1.34","article-title":"B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]","volume":"172","author":"PA Taylor","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ni1102-1056","article-title":"When ligand becomes receptor\u2014tolerance via B7 signaling on DCs","volume":"3","author":"EB Finger","year":"2002","journal-title":"Nature immunology"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD","volume":"23","author":"T Polhill","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"e111285","DOI":"10.1371\/journal.pone.0111285","article-title":"LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity","volume":"9","author":"R Bertelli","year":"2014","journal-title":"PLoS One"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"D Saadoun","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"ref18","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"J Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","article-title":"Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis","volume":"111","author":"D Saadoun","year":"2008","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 Therapy","volume":"6","author":"G Churlaud","year":"2015","journal-title":"Frontiers in immunology"},{"issue":"5769","key":"ref21","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"O Boyman","year":"2006","journal-title":"Science"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1681\/ASN.2012080784","article-title":"IL-2\/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells","volume":"24","author":"MG Kim","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"P Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"P Ravani","year":"2013","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:26:19Z","timestamp":1540218379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138343"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Cravedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138343","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}